Impact of Fibroblast Growth Factor 23 (FGF-23) and Serum Phosphate on Allograft Function and Mortality in Kidney Allograft Recipients

Mahidol University

Status: Unknown

Conditions: Kidney Transplantation

Study type: Observational

Funder types: Other

Identifiers

NCT00903578

KT-1

Details and patient eligibility

About

The present study will examine whether serum FGF-23 and serum phosphate at baseline of kidney transplant recipients can predict progression of allograft dysfunction at 3 years and all-cause mortality at 5 years.

Enrollment: 200 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• at least one year post-transplantation
• no more than 10% increase in serum creatinine for the past 3 months

Exclusion criteria

• refuse to participate in the study
• any acute illnesses

Trial design

200 participants in 1 patient group

Kidney transplant recipients